GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen
- 7 September 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8767), 601-602
- https://doi.org/10.1016/0140-6736(91)90609-s
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantationBlood, 1990
- Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiationBlood, 1989
- RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS THE BEAM REGIMEN INSTEAD OF AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.Proceedings of the National Academy of Sciences, 1987
- Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemiaBlood, 1986
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982